ROSALIND GREEN-RHODEN: Open Payments
NPI 1295279792 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 17 payments from 9 companies in 2025. Trend: 2023 $350 · 2024 $191 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 2 | $147 |
| Lilly USA, LLC | 3 | $64 |
| Amgen Inc. | 4 | $61 |
| ABBVIE INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| PFIZER INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: ACCRUFER, OTEZLA, MOUNJARO, TRELEGY ELLIPTA, QULIPTA, Veozah, FREESTYLE LIBRE 3, AMYVID.
Industry payments across VA — which companies pay providers there.
